Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -101.58 | 33.78 |
| PEG Ratio (TTM) | -8.83 | 2.40 |
| P/S Ratio (TTM) | 2.22 | 14.35 |
| P/B Ratio (TTM) | 2.11 | 17.47 |
| P/FCF Ratio (TTM) | 26.50 | 41.43 |
| Price to 5YR AVG Earnings Ratio | N/A | 15.36 |
| Price to 5YR AVG FCF Ratio | N/A | 57.41 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.04% | 12.83% |
| ROE (TTM) | -2.11% | -4.27% |
| Net Profit Margin (TTM) | -2.07% | 26.05% |
| ROIC 5YR AVG | N/A | 5.46% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 71.12% | 88.20% | N/A |
| Revenue | 1.57% | 17.39% | N/A |
| Net Income | 67.91% | 85.77% | N/A |
| Cash Flow | 76.87% | 47.17% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.60 | 1.38 |
| Quick Ratio (TTM) | 1.60 | 1.36 |
| D/E Ratio (TTM) | 0.76 | 1.12 |
| Interest Coverage (TTM) | 2.14 | 39.34 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.80 | 8.86 |
| LTL to 5YR AVG FCF | N/A | 5.36 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.24% |